Middletown, DE -- (SBWIRE) -- 10/07/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Pixelworks, Inc.(NASDAQ:PXLW), American Capital Ltd.(NASDAQ:ACAS), Halozyme Therapeutics, Inc.(NASDAQ:HALO), VimpelCom Ltd (ADR)(NASDAQ:VIP)
Pixelworks, Inc.(NASDAQ:PXLW) gained volume of 1.44 million shares and the average volume of the stock remained 420,383.00 shares. The 52 week range of the stock remained $2.11 - $5.30 and the day range was $4.67 - $5.05.The stock opened the session at $4.78, and closed the session at $5.01. The stock showed a positive performance of +5.70% in previous trading session. Pixelworks, Inc., together with its subsidiaries, designs, develops, and markets video and pixel processing semiconductors, and software for digital video applications. Its products include ImageProcessor integrated circuits (ICs), which comprise embedded microprocessors, digital signal processing technology.
For How Long PXLW’s Gloss will Attract Investors? Find out via this report
In previous session, American Capital Ltd.(NASDAQ:ACAS) traded 1.47 million shares and the average volume of the stock remained 2.21 million shares. The 52 week range of the stock remained $11.12 - $15.24. The stock was a bull and advanced +0.96%, while its closing price stayed at $13.73. The market capitalization of the stock remained 4.05 billion. The half-yearly trend of the stock remained negative -3.24%. American Capital, Ltd. is a private equity and venture capital firm specializing in management and employee buyouts, leveraged finance, mezzanine, acquisition, recapitalization, middle market, and growth capital investments. The firm seeks to invest in senior debt mezzanine, unitranche, and equity financing for buyouts of private equity firms and direct in private and public companies.
For How Long ACAS will fight for Profitability? Read This Trend Analysis report
Halozyme Therapeutics, Inc.(NASDAQ:HALO) volume of the stock was 1.43 million shares in the most recent session and the average volume remained 1.91 million shares. The stock boosted +2.25% and finished the prior session at the closing price of $10.93. The stock traded 1.43 million shares in its previous trading session and its average volume remained 1.91 million shares. Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human enzymes. Its research focuses on human enzymes that transiently modify tissue under the skin to facilitate the delivery of injected drugs and fluids, or to alter abnormal tissue structures for clinical benefit.
Will HALO Continue To Move Higher? Find Out Here
VimpelCom Ltd (ADR)(NASDAQ:VIP) traded with volume of 1.41 million shares and the average volume of the stock remained 1.25 million shares. The stock finished the trading at $12.40. The market capitalization of the stock remained 25.45 billion. The beta of the stock remained 1.22. VimpelCom Ltd., a telecommunications service operator, provides voice and data services through a range of traditional and broadband mobile and fixed technologies. VimpelCom Ltd. was founded in 2010 and is headquartered in Amsterdam, the Netherlands.
Can Investors Bet on VIP after this News update? Find out in this Research Report
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)